Impact of milk secretor status on the fecal metabolome and microbiota of breastfed infants

Gut Microbes. 2023 Dec;15(2):2257273. doi: 10.1080/19490976.2023.2257273. Epub 2023 Sep 23.

Abstract

Maternal secretor status has been shown to be associated with the presence of specific fucosylated human milk oligosaccharides (HMOs), and the impact of maternal secretor status on infant gut microbiota measured through 16s sequencing has previously been reported. None of those studies have confirmed exclusive breastfeeding nor investigated the impact of maternal secretor status on gut microbial fermentation products. The present study focused on exclusively breastfed (EBF) Indonesian infants, with exclusive breastfeeding validated through the stable isotope deuterium oxide dose-to-mother (DTM) technique, and the impact of maternal secretor status on the infant fecal microbiome and metabolome. Maternal secretor status did not alter the within-community (alpha) diversity, between-community (beta) diversity, or the relative abundance of bacterial taxa at the genus level. However, infants fed milk from secretor (Se+) mothers exhibited a lower level of fecal succinate, amino acids and their derivatives, and a higher level of 1,2-propanediol when compared to infants fed milk from non-secretor (Se-) mothers. Interestingly, for infants consuming milk from Se+ mothers, there was a correlation between the relative abundance of Bifidobacterium and Streptococcus, and between each of these genera and fecal metabolites that was not observed in infants receiving milk from Se- mothers. Our findings indicate that the secretor status of the mother impacts the gut microbiome of the exclusively breastfed infant.

Keywords: Breast milk; exclusive breastfeeding; infant; microbial metabolism; microbiota; oligosaccharides; secretor status.

MeSH terms

  • Breast Feeding
  • Female
  • Gastrointestinal Microbiome*
  • Humans
  • Infant
  • Metabolome
  • Microbiota*
  • Milk, Human / microbiology
  • Oligosaccharides / metabolism

Substances

  • Oligosaccharides

Grants and funding

This research was funded by the Bill & Melinda Gates Foundation (Grant No. OPP1127870). CMS would like to acknowledge support from the USDA National Institute of Food and Agriculture Hatch Project 1021411, and the Kinsella Endowed Chair in Food, Nutrition, and Health.